• Journal of Preventive Medicine and Public Health
• /
• v.49 no.4
• /
• pp.183-196
• /
• 2016

Objectives: There is no systematic review on economic evaluations of telemedicine in Japan, despite over 1000 trials implemented. Our systematic review aims to examine whether Japan's telemedicine is cost-saving or cost-effective, examine the methodological rigorousness of the economic evaluations, and discuss future studies needed to improve telemedicine's financial sustainability. Methods: We searched five databases, including two Japanese databases, to find peer-reviewed articles published between January 1, 2000 and December 31, 2014 in English and Japanese that performed economic evaluations of Japan's telemedicine programs. The methodological rigorousness of the economic analyses was assessed with a well-established checklist. We calculated the benefit-to-cost ratio (BCR) when a reviewed study reported related data but did not report the BCR. All cost values were adjusted to 2014 US dollars. Results: Among the 17 articles identified, six studies reported on settings connecting physicians for specialist consultations, and eleven studies on settings connecting healthcare providers and patients at home. There are three cost-benefit analyses and three cost-minimization analyses. The remaining studies measured the benefit of telemedicine only, using medical expenditure saved or users' willingness-to-pay. There was substantial diversity in the methodological rigorousness. Studies on teledermatology and teleradiology indicated a favorable level of economic efficiency. Studies on telehomecare gave mixed results. One cost-benefit analysis on telehomecare indicated a low economic efficiency, partly due to public subsidy rules, e.g., a too short budget period. Conclusions: Overall, telemedicine programs in Japan were indicated to have a favorable level of economic efficiency. However, the scarcity of the economic literature indicates the need for further rigorous economic evaluation studies.

• Journal of Families and Better Life
• /
• v.17 no.1
• /
• pp.45-56
• /
• 1999

The purpose of this study was to look into correlations between subjective evaluation on the work and self-esteem of the elderly so as to provide information for finding out ways of developing their self-esteem. The subjects of this study were 318 elderly persons in Chonnam and Kwangju city. The statistics used for data analysis were frequency percentage mean standard deviation reliability stepwise and multiple regression analysis through the SAS package program. the major findings of this study can be summarized as follows; 1) The self-esteem of elderly persons was 25,9 which was above the median 24. 2) According to the results related to subjective evaluations on the work among the elderly the positive correlation was by education level family situation economic state social activity level and health state while the negative correlation was by sex, age, and spouse. 3) According to the results related to subjective evaluations on the work among the elderly the positive correl tion was by worker identity job satisfaction quality of work time. 4) In model 1. variable affecting their self-esteem were health sate education level economic state health state age social activity level and sex. In Model 2, variables affecting their self-esteem were worker identity education level economic state age health state social activity level job satisfaction and sex. Especially self-estee of elderly was highly correlated with subjective evaluations on the work among the elderly persons.

• Journal of Preventive Medicine and Public Health
• /
• v.55 no.5
• /
• pp.415-423
• /
• 2022

Economic evaluations in the healthcare are used to assess economic efficiency of pharmaceuticals and medical interventions such as diagnoses and medical procedures. This study introduces the main concepts of economic evaluation across its key steps: planning, outcome and cost calculation, modeling, cost-effectiveness results, uncertainty analysis, and decision-making. When planning an economic evaluation, we determine the study population, intervention, comparators, perspectives, time horizon, discount rates, and type of economic evaluation. In healthcare economic evaluations, outcomes include changes in mortality, the survival rate, life years, and quality-adjusted life years, while costs include medical, non-medical, and productivity costs. Model-based economic evaluations, including decision tree and Markov models, are mainly used to calculate the total costs and total effects. In cost-effectiveness or costutility analyses, cost-effectiveness is evaluated using the incremental cost-effectiveness ratio, which is the additional cost per one additional unit of effectiveness gained by an intervention compared with a comparator. All outcomes have uncertainties owing to limited evidence, diverse methodologies, and unexplained variation. Thus, researchers should review these uncertainties and confirm their robustness. We hope to contribute to the establishment and dissemination of economic evaluation methodologies that reflect Korean clinical and research environment and ultimately improve the rationality of healthcare policies.

• Asian-Australasian Journal of Animal Sciences
• /
• v.31 no.1
• /
• pp.19-25
• /
• 2018

Objective: In practical breeding, selection is often performed by ignoring the accuracy of evaluations and applying economic weights directly to the selection index coefficients of genetically standardized traits. The denominator of the standardized component trait of estimated genetic evaluations in practical selection varies with its reliability. Whereas theoretical methods for calculating the selection index coefficients of genetically standardized traits account for this variation, practical selection ignores reliability and assumes that it is equal to unity for each trait. The purpose of this study was to clarify the effects of ignoring the accuracy of the standardized component trait in selection criteria on selection responses and economic weights in retrospect. Methods: Theoretical methods were presented accounting for reliability of estimated genetic evaluations for the selection index composed of genetically standardized traits. Results: Selection responses and economic weights in retrospect resulting from practical selection were greater than those resulting from theoretical selection accounting for reliability when the accuracy of the estimated breeding value (EBV) or genomically enhanced breeding value (GEBV) was lower than those of the other traits in the index, but the opposite occurred when the accuracy of the EBV or GEBV was greater than those of the other traits. This trend was more conspicuous for traits with low economic weights than for those with high weights. Conclusion: Failure of the practical index to account for reliability yielded economic weights in retrospect that differed from those obtained with the theoretical index. Our results indicated that practical indices that ignore reliability delay genetic improvement. Therefore, selection practices need to account for reliability, especially when the reliabilities of the traits included in the index vary widely.

• Health Policy and Management
• /
• v.14 no.2
• /
• pp.58-77
• /
• 2004

Cost containment has become high political issues since financial crisis of the Korean Health Insurance fund in 2000. Korean Government has developed and implemented several measures to reduce the pharmaceutical expenditures. Pharmaceutical economic evaluation can be a tool in decision to allocate scare resource efficiently. In order to increase the quality of economic evaluation for pharmaceuticals, the Korean Health Insurance Review Agency(HIRA) is considering the development of a guideline for economic evaluation. It mandates that pharmaceutical companies could submit the result of an economic evaluation when demanding reimbursement of new pharmaceutical drugs. The purpose of this study is to provide a critical review of the economic evaluations of health care technologies published in the Korean context whether they have been performed according to current guidelines and therefore whether their results are directly useful for decision making. We found there exist important problems and deviation from, good practice' both in the general features of the studies, like the study design and perspective, and in terms of cost measurement and valuation. There are needs to develop clear guidelines and to educate and train researchers in performing economic evaluations.

• Asia Marketing Journal
• /
• v.12 no.3
• /
• pp.63-79
• /
• 2010

This research examined (1) the effects of the large scaled corporations' performances in the area of corporate economic responsibilities and corporate philanthropic responsibilities on the anti-corporate sentiments and (2) the effects of the anti-corporate sentiments on the consumers' evaluations of the large scaled corporations. The results of path analysis revealed that the corporate performances in philanthropic responsibilities had a negative effect on the anti-corporate sentiments as expected. However, different from the expectation, the corporate performances in economic responsibilities had a positive influence on the anti-corporate sentiments. This unexpected relationship between economic responsibilities and anti-corporate sentiments might be caused by the Korean consumers' perceptions that the more the large scaled corporations conducted their business activities illegally and unethically, that the more they achieved the various economic responsibilities. The anti-corporate sentiments showed the negative effects on the consumers' evaluations of the large scaled corporations.

• The Transactions of The Korean Institute of Electrical Engineers
• /
• v.60 no.3
• /
• pp.500-508
• /
• 2011

In the distribution systems, the maximum power transportation capacity is restricted within 40MW based on two lines, because of the thermal current limit of a distribution line. Recently it has been continuously required to expand the abilities of the power transportation in distribution systems, as the number of large scale industrial complexes and distributed generations are growing. In this paper, we suggested the five alternatives combining two methods, laying the two bundle lines and adding another voltage between the 22.9kV and 154kV in distribution systems. This paper implemented the economic evaluations of proposed alternatives from national and customer perspectives. And then we compare the results with those of 154kV transmission system.

• Journal of the Korea Academia-Industrial cooperation Society
• /
• v.21 no.9
• /
• pp.380-386
• /
• 2020

The ESS load test device (ELTD) can store and exchange electrical energy during the load test of an emergency generator. On the other hand, it is difficult to commercialize ELTDs based on Li-ion batteries because of the high initial cost, which is higher than a load bank test. If the trade of electrical energy stored in ELTD during the test of an emergency generator is considered, it may be possible to commercialize the ELTD. Therefore, this paper proposes an economic model of ELTD composed of the costs and benefits by considering electrical energy trade to perform accurately economic evaluations of an ELTD. From the simulation results of the economic evaluations of an ELTD and the load bank method, it was found that the commercialization of ELTD is possible when the trade in electrical energy in ELTDs is considered.

• 대한임상약리학회:학술대회논문집
• /
• 2004.12a
• /
• pp.19-20
• /
• 2004

• Journal of Preventive Medicine and Public Health
• /
• v.41 no.2
• /
• pp.74-79
• /
• 2008

Since the positive listing system for prescription drug reimbursement has been introduced in Korea, the number of pharmacoeconomic evaluation studies has increased. However it is not clear if the quality of pharmacoeconomic evaluation study has improved. Due to the lack of randomized clinical studies in Korean health care setting, Korean economic evaluation studies have typically integrated the local cost data and foreign clinical data. Therefore methodological issues can be raised in regard to data coherence and consistency. But the quality of data was not questiened and the potential bias has not been investigated yet. Even though changes in policy have encouraged the undertaking of pharmacoeconomic evaluations, there is few public-side funding for validation study of cost-effectiveness models and data. Several companies perform economic evaluation studies to be submitted on behalf of their own products, but do not want the study results to be disclosed to the academic community or public. To improve the present conduct of pharmacoeconomic evaluations in Korea, various funding sources need to be developed, and, like other multidisciplinary areas, the experts in different fields of study should collaborate to ensure the validity and credibility of pharmacoeconomic evaluations.